UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in ApcMin/+ mice

Journal of applied microbiology, 2017-03, Vol.122 (3), p.770-784

2017

Volltextzugriff (PDF)

A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in Apc Min/+ mice

Journal of applied microbiology, 2017-03, Vol.122 (3), p.770-784

2017

Volltextzugriff (PDF)

CLINICAL MARKERS THAT ENHANCE ETIOLOGIC YIELD IN GLOBAL DEVELOPMENTAL DELAY

Pediatrics (Evanston), 2008-01, Vol.121 (Supplement_2), p.S145-S146

2008

Volltextzugriff (PDF)

Meta‐analysis: the association of hepatitis B virus genotypes and hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2013-03, Vol.37 (5), p.517-526

2013

Volltextzugriff (PDF)

Meta‐analysis: the efficacy of anti‐viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B‐related hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2011-05, Vol.33 (10), p.1104-1112

2011

Volltextzugriff (PDF)

Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population

Alimentary pharmacology & therapeutics, 2017-08, Vol.46 (4), p.447-456

2017

Volltextzugriff (PDF)

PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

Alimentary pharmacology & therapeutics, 2014-03, Vol.39 (5), p.532-539

2014

Volltextzugriff (PDF)

Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B

Journal of viral hepatitis, 2009-01, Vol.16 (1), p.36-44

2009

Volltextzugriff (PDF)

Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B

Alimentary pharmacology & therapeutics, 2010-12, Vol.32 (11‐12), p.1323-1331

2010

Volltextzugriff (PDF)

Short- and potential long-term adverse health outcomes of COVID-19: a rapid review

Emerging microbes & infections, 2020-01, Vol.9 (1), p.2190-2199

2020

Volltextzugriff (PDF)

Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments

Alimentary pharmacology & therapeutics, 2014-02, Vol.39 (3), p.254-269

2014

Volltextzugriff (PDF)

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (6), p.617-627

2017

Volltextzugriff (PDF)

Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis

Alimentary pharmacology & therapeutics, 2017-11, Vol.46 (10), p.1001-1010

2017

Volltextzugriff (PDF)

Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B – a prospective cohort study with paired transient elastography examinations

Alimentary pharmacology & therapeutics, 2014-04, Vol.39 (8), p.883-893

2014

Volltextzugriff (PDF)

Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years

Alimentary pharmacology & therapeutics, 2012-06, Vol.35 (11), p.1326-1335

2012

Volltextzugriff (PDF)

Liver fibrosis and fatty liver in Asian HIV‐infected patients

Alimentary pharmacology & therapeutics, 2016-08, Vol.44 (4), p.411-421

2016

Volltextzugriff (PDF)

Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (2), p.175-182

2017

Volltextzugriff (PDF)

Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (6), p.730-737

2018

Volltextzugriff (PDF)

Non‐invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B

Alimentary pharmacology & therapeutics, 2014-01, Vol.39 (2), p.197-208

2014

Volltextzugriff (PDF)

Monocyte function in cervical carcinoma: Plasma inhibitor of monocyte chemotaxis

Gynecologic oncology, 1985-02, Vol.20 (2), p.170-176

1985

Volltextzugriff (PDF)

HLA-B38:02:01 predicts carbimazole/methimazole-induced agranulocytosis

Clinical pharmacology and therapeutics, 2016-05, Vol.99 (5), p.555-561

2016

Volltextzugriff (PDF)

Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1

International journal of cancer, 2012-03, Vol.130 (5), p.1036-1045

2012

Volltextzugriff (PDF)

Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers

Alimentary pharmacology & therapeutics, 2012-12, Vol.36 (11-12), p.1057-1066

2012

Volltextzugriff (PDF)

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

Gut, 2009-01, Vol.58 (1), p.111-117

2009

Volltextzugriff (PDF)

Bacterial endotoxin and non‐alcoholic fatty liver disease in the general population: a prospective cohort study

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.731-740

2015

Volltextzugriff (PDF)

1 – 25 von 1.699

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.550)
Mit Volltextzugriff
(1.462)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in ApcMin/+ mice

A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in Apc Min/+ mice

CLINICAL MARKERS THAT ENHANCE ETIOLOGIC YIELD IN GLOBAL DEVELOPMENTAL DELAY

Meta‐analysis: the association of hepatitis B virus genotypes and hepatocellular carcinoma

Meta‐analysis: the efficacy of anti‐viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B‐related hepatocellular carcinoma

Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population

PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B

Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B

Short- and potential long-term adverse health outcomes of COVID-19: a rapid review

Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis

Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B – a prospective cohort study with paired transient elastography examinations

Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years

Liver fibrosis and fatty liver in Asian HIV‐infected patients

Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease

Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B

Non‐invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B

Monocyte function in cervical carcinoma: Plasma inhibitor of monocyte chemotaxis

HLA-B38:02:01 predicts carbimazole/methimazole-induced agranulocytosis

Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1

Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

Bacterial endotoxin and non‐alcoholic fatty liver disease in the general population: a prospective cohort study

Suchergebnisse filtern